Cell Bio Human TechLtd (A318160) Stock Overview
Develops nonwoven fabric materials for sheet masks in Korea and Vietnam. More details
| Snowflake Score | |
|---|---|
| Valuation | 3/6 |
| Future Growth | 4/6 |
| Past Performance | 4/6 |
| Financial Health | 5/6 |
| Dividends | 0/6 |
A318160 Community Fair Values
Create NarrativeSee what others think this stock is worth. Follow their fair value or set your own to get alerts.
An Undervalued 3.3Moz Gold Project in Canada
Key takeaways Upside Gold is developing the Kena Gold Project, near the town of Nelson in the Kootenays region of southern British Columbia. Kena hosts a historical gold resource of 3.33 million ounces (561,000 ounces Indicated and 2.77 million ounces Inferred) across a 10,200-hectare land package.Read more
Cell Bio Human Tech Co.,Ltd Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ₩6,890.00 |
| 52 Week High | ₩11,510.00 |
| 52 Week Low | ₩3,820.00 |
| Beta | 0.59 |
| 1 Month Change | -19.04% |
| 3 Month Change | -16.28% |
| 1 Year Change | 77.58% |
| 3 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | -31.78% |
Recent News & Updates
We Ran A Stock Scan For Earnings Growth And Cell Bio Human TechLtd (KOSDAQ:318160) Passed With Ease
Feb 16
Cell Bio Human Tech Co.,Ltd's (KOSDAQ:318160) Business Is Trailing The Industry But Its Shares Aren't
Nov 21Is Now The Time To Put Cell Bio Human TechLtd (KOSDAQ:318160) On Your Watchlist?
Oct 16Recent updates
We Ran A Stock Scan For Earnings Growth And Cell Bio Human TechLtd (KOSDAQ:318160) Passed With Ease
Feb 16Cell Bio Human Tech Co.,Ltd's (KOSDAQ:318160) Business Is Trailing The Industry But Its Shares Aren't
Nov 21Is Now The Time To Put Cell Bio Human TechLtd (KOSDAQ:318160) On Your Watchlist?
Oct 16Cell Bio Human Tech Co.,Ltd (KOSDAQ:318160) Stock Rockets 30% As Investors Are Less Pessimistic Than Expected
Aug 20Returns At Cell Bio Human TechLtd (KOSDAQ:318160) Appear To Be Weighed Down
Jul 21Cell Bio Human Tech Co.,Ltd's (KOSDAQ:318160) Shares Climb 26% But Its Business Is Yet to Catch Up
Jun 16Cell Bio Human Tech Co.,Ltd's (KOSDAQ:318160) 27% Price Boost Is Out Of Tune With Revenues
Apr 11Cell Bio Human TechLtd (KOSDAQ:318160) Could Be Struggling To Allocate Capital
Mar 21Cell Bio Human Tech Co.,Ltd's (KOSDAQ:318160) Share Price Is Matching Sentiment Around Its Revenues
Dec 15Is Cell Bio Human TechLtd (KOSDAQ:318160) A Risky Investment?
Oct 23Cell Bio Human Tech (KOSDAQ:318160) Seems To Use Debt Rather Sparingly
Jun 27Does Cell Bio Human Tech (KOSDAQ:318160) Have A Healthy Balance Sheet?
Mar 13Shareholder Returns
| A318160 | KR Chemicals | KR Market | |
|---|---|---|---|
| 7D | -12.5% | 8.3% | 7.3% |
| 1Y | 77.6% | 59.3% | 135.0% |
Return vs Industry: A318160 exceeded the KR Chemicals industry which returned 59.3% over the past year.
Return vs Market: A318160 underperformed the KR Market which returned 135% over the past year.
Price Volatility
| A318160 volatility | |
|---|---|
| A318160 Average Weekly Movement | 8.2% |
| Chemicals Industry Average Movement | 6.1% |
| Market Average Movement | 6.7% |
| 10% most volatile stocks in KR Market | 13.5% |
| 10% least volatile stocks in KR Market | 3.0% |
Stable Share Price: A318160 has not had significant price volatility in the past 3 months compared to the KR market.
Volatility Over Time: A318160's weekly volatility (8%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2015 | 72 | KwonSun Lee | cellbiohumantech.co.kr |
Cell Bio Human Tech Co.,Ltd develops nonwoven fabric materials for sheet masks in Korea and Vietnam. The company provides sheet masks, patches, skincare products, etc. Its nonwoven fabric materials include PT CELL, a cellulose sheet made from bamboo; SEMI GEL and NC Cell, which are made of lyocell material; and SCell, which is made of rayon material, as well as cotton, microfiber, and PET. The company also offers dried hydrogel sheets and dried biocellulose fabrics.
Cell Bio Human Tech Co.,Ltd Fundamentals Summary
| A318160 fundamental statistics | |
|---|---|
| Market cap | ₩56.18b |
| Earnings (TTM) | ₩8.48b |
| Revenue (TTM) | ₩45.07b |
Is A318160 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| A318160 income statement (TTM) | |
|---|---|
| Revenue | ₩45.07b |
| Cost of Revenue | ₩27.83b |
| Gross Profit | ₩17.24b |
| Other Expenses | ₩8.76b |
| Earnings | ₩8.48b |
Last Reported Earnings
Sep 30, 2025
Next Earnings Date
n/a
| Earnings per share (EPS) | 1.04k |
| Gross Margin | 38.26% |
| Net Profit Margin | 18.81% |
| Debt/Equity Ratio | 13.5% |
How did A318160 perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2026/03/01 16:22 |
| End of Day Share Price | 2026/02/27 00:00 |
| Earnings | 2025/09/30 |
| Annual Earnings | 2024/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Cell Bio Human Tech Co.,Ltd is covered by 1 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Hyun Dong Sung | KB Securities Co., Ltd. |